NL7503310A - Verbindingen met antidepressieve werking. - Google Patents

Verbindingen met antidepressieve werking.

Info

Publication number
NL7503310A
NL7503310A NL7503310A NL7503310A NL7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A NL 7503310 A NL7503310 A NL 7503310A
Authority
NL
Netherlands
Prior art keywords
connections
antidepressive action
antidepressive
action
Prior art date
Application number
NL7503310A
Other languages
English (en)
Dutch (nl)
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Priority to NL7503310A priority Critical patent/NL7503310A/xx
Priority to ZA761434A priority patent/ZA761434B/xx
Priority to DE19762610886 priority patent/DE2610886A1/de
Priority to FI760699A priority patent/FI61875C/fi
Priority to GB10703/76A priority patent/GB1535226A/en
Priority to DK115976A priority patent/DK144942C/da
Priority to CA248,102A priority patent/CA1076142A/en
Priority to DD7600191893A priority patent/DD128332A5/xx
Priority to PL1976199556A priority patent/PL100052B1/pl
Priority to SE7603341A priority patent/SE410312B/xx
Priority to PL1976199557A priority patent/PL101951B1/pl
Priority to IT21320/76A priority patent/IT1063064B/it
Priority to AT195476A priority patent/AT340895B/de
Priority to HU76PI00000513A priority patent/HU171030B/hu
Priority to CH334576A priority patent/CH626057A5/de
Priority to IL49238A priority patent/IL49238A/xx
Priority to PL1976188006A priority patent/PL100614B1/pl
Priority to GR50333A priority patent/GR60052B/el
Priority to SU762335241A priority patent/SU635867A3/ru
Priority to YU714/76A priority patent/YU39345B/xx
Priority to ES446192A priority patent/ES446192A1/es
Priority to BE165316A priority patent/BE839744A/xx
Priority to AU12147/76A priority patent/AU505358B2/en
Priority to IE567/76A priority patent/IE43768B1/en
Priority to FR7608019A priority patent/FR2304336A1/fr
Priority to JP51029394A priority patent/JPS6026776B2/ja
Priority to US05/668,461 priority patent/US4085225A/en
Priority to AR262650A priority patent/AR211011A1/es
Publication of NL7503310A publication Critical patent/NL7503310A/xx
Priority to AR265801A priority patent/AR211153A1/es
Priority to AT41377A priority patent/AT342568B/de
Priority to AT317277A priority patent/AT342574B/de
Priority to SU772503814A priority patent/SU645559A3/ru
Priority to SU772503815A priority patent/SU620206A3/ru
Priority to CH153981A priority patent/CH629184A5/de
Priority to CH154081A priority patent/CH629477A5/de
Priority to CH154181A priority patent/CH629761A5/de
Priority to MX9203723A priority patent/MX9203723A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7503310A 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking. NL7503310A (nl)

Priority Applications (37)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.
ZA761434A ZA761434B (en) 1975-03-20 1976-03-09 Compounds having anti-depressive activity
DE19762610886 DE2610886A1 (de) 1975-03-20 1976-03-16 Verbindungen mit antidepressiver wirkung
GR50333A GR60052B (en) 1975-03-20 1976-03-17 Preparation process of anti-depressive compounds
GB10703/76A GB1535226A (en) 1975-03-20 1976-03-17 Oximes
DK115976A DK144942C (da) 1975-03-20 1976-03-17 Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte
CA248,102A CA1076142A (en) 1975-03-20 1976-03-17 Substituted butyrophenone o-(2-aminoethyl) oxime derivatives
DD7600191893A DD128332A5 (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von verbindungen mit antidepressiver wirkung
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu
SE7603341A SE410312B (sv) 1975-03-20 1976-03-17 Forfarande for framstellning av vissa angivna oximetrar
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
IT21320/76A IT1063064B (it) 1975-03-20 1976-03-17 Composti aventi attivita antidepressiva a base di eteri ossimici derivati da fenilchetoni
AT195476A AT340895B (de) 1975-03-20 1976-03-17 Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
HU76PI00000513A HU171030B (hu) 1975-03-20 1976-03-17 Sposob poluchenija novykh oksim-ehfirnykh soedinenij s antidepressivnoj aktivnost'ju
CH334576A CH626057A5 (enExample) 1975-03-20 1976-03-17
IL49238A IL49238A (en) 1975-03-20 1976-03-17 O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu
FI760699A FI61875C (fi) 1975-03-20 1976-03-17 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara trifluormetylfenon-0-(2-aminoetyl)-oximer
SU762335241A SU635867A3 (ru) 1975-03-20 1976-03-17 Способ получени производных оксима или их солей
IE567/76A IE43768B1 (en) 1975-03-20 1976-03-18 Oximes
YU714/76A YU39345B (en) 1975-03-20 1976-03-18 Process for preparing new oxime ether compounds
ES446192A ES446192A1 (es) 1975-03-20 1976-03-18 Un metodo de preparacion de nuevos compuestos de oxima-eter.
BE165316A BE839744A (fr) 1975-03-20 1976-03-18 Composes a effet anti-depressif et procedes de preparation
AU12147/76A AU505358B2 (en) 1975-03-20 1976-03-18 Alkylphenone-0-(aminoethyl)oxime derivatives
FR7608019A FR2304336A1 (fr) 1975-03-20 1976-03-19 Composes a effet anti-depressif et procedes de preparation
JP51029394A JPS6026776B2 (ja) 1975-03-20 1976-03-19 新規オキシムエーテル化合物
US05/668,461 US4085225A (en) 1975-03-20 1976-03-19 Oxime ethers having anti-depressive activity
AR262650A AR211011A1 (es) 1975-03-20 1976-03-22 Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c3-c4)-sustuitido-ptrifluormetilfenilcetoxin
AR265801A AR211153A1 (es) 1975-03-20 1976-12-10 Metodo para producir compuestos de eteres de o-(aminocetil-n-alquil(c3-c4)-sustituido-p-triflourmetilfenilcetoxima.
AT41377A AT342568B (de) 1975-03-20 1977-01-24 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen
AT317277A AT342574B (de) 1975-03-20 1977-05-04 Verfahren zur herstellung von neuen p-trifluormethyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen
SU772503814A SU645559A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
SU772503815A SU620206A3 (ru) 1975-03-20 1977-07-12 Способ получени производных оксима или их солей
CH153981A CH629184A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154081A CH629477A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
CH154181A CH629761A5 (de) 1975-03-20 1981-03-06 Verfahren zur herstellung neuer oximaetherverbindungen.
MX9203723A MX9203723A (es) 1975-03-20 1992-06-29 Compuestos que tienen actividad anti-depresiva.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
NL7503310A true NL7503310A (nl) 1976-09-22

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Country Status (27)

Country Link
US (1) US4085225A (enExample)
JP (1) JPS6026776B2 (enExample)
AR (2) AR211011A1 (enExample)
AT (1) AT340895B (enExample)
AU (1) AU505358B2 (enExample)
BE (1) BE839744A (enExample)
CA (1) CA1076142A (enExample)
CH (4) CH626057A5 (enExample)
DD (1) DD128332A5 (enExample)
DE (1) DE2610886A1 (enExample)
DK (1) DK144942C (enExample)
ES (1) ES446192A1 (enExample)
FI (1) FI61875C (enExample)
FR (1) FR2304336A1 (enExample)
GB (1) GB1535226A (enExample)
GR (1) GR60052B (enExample)
HU (1) HU171030B (enExample)
IE (1) IE43768B1 (enExample)
IL (1) IL49238A (enExample)
IT (1) IT1063064B (enExample)
MX (1) MX9203723A (enExample)
NL (1) NL7503310A (enExample)
PL (3) PL101951B1 (enExample)
SE (1) SE410312B (enExample)
SU (3) SU635867A3 (enExample)
YU (1) YU39345B (enExample)
ZA (1) ZA761434B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
WO1997006792A1 (en) * 1995-08-16 1997-02-27 Eli Lilly And Company Potentiation of serotonin response
IN182588B (enExample) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (enExample) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
EP1276478A2 (en) 2000-04-24 2003-01-22 ARYx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
NZ532033A (en) * 2001-10-12 2006-11-30 Azevan Pharmaceuticals Inc 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives as vasopressin V1a receptor antagonists
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
CA2532207A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
DE602004024317D1 (de) 2003-09-12 2010-01-07 Pfizer Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
US7671072B2 (en) * 2003-11-26 2010-03-02 Pfizer Inc. Aminopyrazole derivatives as GSK-3 inhibitors
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
MXPA06012165A (es) * 2004-04-29 2007-01-17 Keystone Retaining Wall System Chapas para muros, muros de contencion y similares.
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
EP1868434A4 (en) 2005-03-22 2011-10-26 Azevan Pharmaceuticals Inc BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS
AU2006239942A1 (en) * 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
AU2006239897A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
AU2006239920A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
JP2008538573A (ja) * 2005-04-22 2008-10-30 ワイス ベンゾフラニルアルカナミン誘導体およびその５−ｈｔ２ｃアゴニストとしての使用
US20070015138A1 (en) * 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
TR201907381T4 (tr) 2005-07-19 2019-06-21 Azevan Pharmaceuticals Inc Beta-laktamil fenilalanin, sistein ve serin vazopressin antagonisti.
KR20080039876A (ko) * 2005-07-22 2008-05-07 미리어드 제네틱스, 인크. 높은 약물 충진 제형 및 투여형
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CN101410112A (zh) * 2006-03-24 2009-04-15 惠氏公司 治疗抑郁症的新治疗组合
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
EP2125017A2 (en) * 2007-01-11 2009-12-02 Braincells, Inc. Modulation of neurogenesis with use of modafinil
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
ES2585806T3 (es) 2009-10-23 2016-10-10 Janssen Pharmaceutica N.V. Octahidropirrolo [3,4-c] pirroles disustituidos como moduladores de receptores de orexina
EP2509596B1 (en) 2009-12-08 2019-08-28 Case Western Reserve University Gamma aminoacids for treating ocular disorders
ES2662350T3 (es) 2010-07-01 2018-04-06 Azevan Pharmaceuticals, Inc. Procedimientos para el tratamiento del trastorno por estrés postraumático
US20140010883A1 (en) 2011-03-17 2014-01-09 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
US9783492B2 (en) 2013-04-03 2017-10-10 Zcl Chemicals Limited Process for the preparation of fluvoxamine maleate
US10124006B2 (en) 2014-02-07 2018-11-13 MTA Tämogatott Kutatócsoportok Irodája Use of Sigma-1 receptor agonist compounds
AU2015237253B2 (en) 2014-03-28 2019-11-14 Azevan Pharmaceuticals, Inc. Compositions and methods for treating neurodegenerative diseases
HRP20220642T1 (hr) 2016-03-10 2022-06-24 Janssen Pharmaceutica Nv Postupci za liječenje depresije uporabom antagonista receptora oreksina 2
MA46898A (fr) 2016-11-24 2019-10-02 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Compositions pour la conservation d'organes
MY208313A (en) 2017-09-15 2025-04-30 Azevan Pharmaceuticals Inc Compositions and methods for treating brain injury
US20240024288A1 (en) 2019-07-19 2024-01-25 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2343073A2 (en) 2003-12-11 2011-07-13 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression

Also Published As

Publication number Publication date
YU71476A (en) 1982-10-31
DK144942B (da) 1982-07-12
FR2304336A1 (fr) 1976-10-15
DK144942C (da) 1982-12-06
DE2610886A1 (de) 1976-10-07
SU620206A3 (ru) 1978-08-15
SE7603341L (sv) 1976-09-21
YU39345B (en) 1984-10-31
PL100614B1 (pl) 1978-10-31
CH629761A5 (de) 1982-05-14
CH629184A5 (de) 1982-04-15
AU505358B2 (en) 1979-11-15
AT340895B (de) 1978-01-10
FI61875C (fi) 1982-10-11
US4085225A (en) 1978-04-18
DD128332A5 (de) 1977-11-09
JPS6026776B2 (ja) 1985-06-25
FR2304336B1 (enExample) 1979-09-28
IL49238A0 (en) 1976-05-31
ZA761434B (en) 1977-10-26
JPS51125345A (en) 1976-11-01
GR60052B (en) 1978-04-04
DE2610886C2 (enExample) 1987-09-24
IL49238A (en) 1978-08-31
CH626057A5 (enExample) 1981-10-30
AU1214776A (en) 1977-09-22
FI760699A7 (enExample) 1976-09-21
DK115976A (da) 1976-09-21
ATA195476A (de) 1977-05-15
BE839744A (fr) 1976-09-20
GB1535226A (en) 1978-12-13
AR211011A1 (es) 1977-10-14
SU635867A3 (ru) 1978-11-30
SU645559A3 (ru) 1979-01-30
IE43768B1 (en) 1981-05-20
AR211153A1 (es) 1977-10-31
PL100052B1 (pl) 1978-08-31
MX9203723A (es) 1992-07-01
IT1063064B (it) 1985-02-11
FI61875B (fi) 1982-06-30
IE43768L (en) 1976-09-20
CH629477A5 (de) 1982-04-30
SE410312B (sv) 1979-10-08
ES446192A1 (es) 1977-10-01
HU171030B (hu) 1977-10-28
CA1076142A (en) 1980-04-22
PL101951B1 (pl) 1979-02-28

Similar Documents

Publication Publication Date Title
NL178089C (nl) Windmotor.
NO144499C (no) Vaeskesonde.
NO143239C (no) Pumpeanordning.
ES223804Y (es) Batidora-calentadora.
NL7611944A (nl) 1,2,3-triazolen met kalmerende werking.
NO147432C (no) Roterovnsanlegg.
NO141839C (no) Enkeltpunkts-fortoeyningsboeye.
ES220892Y (es) Clavo-grapa.
NO136697C (no) Skistav.
NL7503312A (nl) Verbindingen met antidepressieve werking.
NO143735C (no) Pullertanordning.
NL7504369A (nl) Terpenofenolen met farmacologische werking.
NL7504370A (nl) Terpenofenoxyalkylaminen met farmacologische werking.
SE7612368L (sv) Tiaprostaglandiner.
NL7504371A (nl) Heihamer.
NL7503309A (nl) Verbindingen met antidepressieve werking.
NL7503311A (nl) Verbindingen met antidepressieve werking.
NO142126C (no) Smoeremiddeltilsetning.
BE849303A (fr) Tranducteur.
NL7600039A (nl) 5-fenyl-2-furamidoximen.
NL7610639A (nl) Schouw.
NO152521C (no) Fjellboreverktoey.
NL7503308A (nl) Verbindingen met antidepressieve werking.
NL7503307A (nl) Antidepressieve verbindingen.
NL7609280A (nl) Fenylsulfenylpiperazinen.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: DUPHAR INTERNATIONAL RESEARCH B.V.

BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed